Skip to main content
. 2020 Feb 27;8(3):44. doi: 10.3390/biomedicines8030044

Table 5.

Genotypic and allelic frequencies APOA2 rs3813627 polymorphism.

Condition/Models Codominant Dominant Recessive Log-Additive
OR
(95% CI) het
OR
(95% CI) hom
p OR
(95% CI)
p OR
(95% CI)
p OR
(95% CI)
p
HDL
Model 1 0.64
(0.24–1.74)
3.09
(0.85–11.21)
0.065 1.02
(0.43–2.45)
0.956 3.76
(1.11–12.71)
0.030 * 1.42
(0.77–2.62)
0.256
Model 2 0.62
(0.22–1.69)
3.03
(0.81–11.29)
0.066 0.99
(0.41–2.40)
0.979 3.76
(1.09–13.02)
0.033 * 1.40
(0.75–2.60)
0.288
APOA1
Model 1 0.45
(0.12–1.75)
2.77
(0.71–10.88)
0.055 0.97
(0.33–2.86)
0.952 3.89
(1.10–13.81)
0.035 * 1.49 (0.74–3.03) 0.265
Model 2 0.46
(0.12–1.76)
2.82
(0.71–11.12)
0.054 0.98
(0.33–2.89)
0.964 3.94
(1.11–14.08)
0.034 * 1.50
(0.74–3.06)
0.257

Multiple logistic regression analysis of the APOA2 rs3813627 polymorphism was carried out in overweight/obese individuals (BMI ≥ 25 kg/m2), taking the APOA2 rs3813627 variant as independent variables an HDL (n = 91) and APOA1 levels (n = 65) as dependent variables. The APOA2 rs3813627 GG genotype was considered as the reference category. Model 1 was carried out without adjusting and Model 2 was performed after adjusting by sex (* p  <  0.05). The multiple logistic regression analysis was analyzed to determine the risk associated with low HDL and APOA1 levels. Abbreviations: BMI, body mass index; HDL, high density lipoprotein; APOA1, apolipoprotein type A1; OR, odds ratio; CI, confidence interval.